A new survey reveals most cannabis consumers consider candidates' marijuana stances crucial to their vote, with key ballot initiatives in Massachusetts, Idaho, and Texas.

A latest federal court ruling risks unraveling commercial reliability in legal state cannabis markets. NORML urges that enforceable contracts are critical for consumer safety and industry trust.

NORML files an amicus brief urging the Sixth Circuit to reconsider invalidating marijuana business contracts, warning of consumer safety risks.

Gov. Maura Healey says she’ll vote no on Question 8, the repeal bid targeting Massachusetts’ adult-use market, as polling shows 71% opposition and top Democrats urge voters to keep cannabis legal.

High Times reports NORML’s Paul Armentano sees a two-front squeeze: GOP rollbacks in several states and Democratic tax hikes in others. Here’s what DMV consumers should watch.

A University of Michigan–led analysis reported in Annals of Internal Medicine finds a 16% rise since 2020 in U.S. clinicians authorizing medical cannabis, with millions of patients participating.

NORML’s op-ed warns voters about a repeal push in Massachusetts and argues legal markets protect youth better than prohibition. Here’s what’s at stake and why DMV readers should watch.

Latest polling shows voters overwhelmingly opposing Question 8 as the election approaches, signaling strong support for adult-use markets.

FBI-linked figures show more than 200,000 cannabis arrests in 2025—mostly for possession. Here’s what that means for DMV residents and why delivery compliance matters.

New compliance-check findings suggest licensed cannabis shops outpace alcohol retailers at enforcing minimum-age rules—shaping delivery protocols and ID checks across the DMV.

NORML reports the latest CDC findings show high school marijuana use at a historic low — a data point likely to shape youth access rules, delivery compliance, and policy debates in the DMV.

NORML’s new op-ed challenges The New York Times’ framing of cannabis. Here’s why that media narrative matters for delivery rules, licensing, and consumer safety in the DMV.

A new Elon University poll shows strong support in North Carolina for medical cannabis and a narrow majority for adult-use. Here’s what it could mean for delivery, policing, and the DMV.

Fresh FBI data show more than half of last year’s cannabis arrests came from just 10 states. Here’s what that pattern means for DMV residents, delivery compliance, and risk planning.

NORML reports a decade-long study in back pain patients linking medical cannabis therapy to sustained pain relief and sharply reduced reliance on pharmaceuticals.

What cannabigerol (CBG) is, why scientists call it cannabis’s precursor cannabinoid, what preclinical research suggests, and how DMV patients should approach it today.

New SAMHSA data shows continued declines in past-month and past-year cannabis use among 12–25 year-olds. Here’s what changed, why it matters, and how DMV policymakers may apply it.

NORML reports, citing FBI data, that in six states marijuana accounts for the majority of drug-related arrests — highlighting stark differences in enforcement and compliance risks.

NORML reports a pediatric clinical trial found a plant-derived cannabis preparation was safe and effective for autism, with disease severity falling about 2 points on a 7‑point scale after eight weeks.

Fresh FBI crime data show over 200,000 cannabis possession arrests in 2025—about 23% of all U.S. drug arrests. Here’s what the trend means and how the DMV should read it.